{
    "root": "2bd614b6-02ce-49e3-86e2-dfaec7a13e04",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "CALCIUM GLUCONATE",
    "value": "20240418",
    "ingredients": [
        {
            "name": "CALCIUM GLUCONATE MONOHYDRATE",
            "code": "CZN0MI5R31"
        },
        {
            "name": "CALCIUM SACCHARATE",
            "code": "6AP9J91K4V"
        },
        {
            "name": "HYDROCHLORIC ACID",
            "code": "QTT17582CB"
        },
        {
            "name": "SODIUM HYDROXIDE",
            "code": "55X04QC32I"
        },
        {
            "name": "SODIUM CHLORIDE",
            "code": "451W47IQ8X"
        },
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        }
    ],
    "indications": "calcium gluconate sodium chloride injection indicated pediatric adult patients treatment acute symptomatic hypocalcemia . limitations safety calcium gluconate injection long term established .",
    "contraindications": "contains 20 mg calcium gluconate per ml contains 1.86 mg ( 0.093 meq ) elemental calcium . ( 2.1 ) administer intravenously ( bolus continuous infusion ) via secure intravenous line . ( 2.1 ) full prescribing information ( fpi ) rates appropriate monitoring . ( 2.1 ) dilute calcium gluconate sodium chloride injection prior . unused portion discarded . ( 2.1 ) individualize dose within recommended range adults pediatric patients depending severity symptoms hypocalcemia , serum calcium level acuity onset hypocalcemia . table 2 fpi dosing recommendations mg calcium gluconate neonates , pediatric adult patients . ( 2.2 ) measure serum calcium intermittent infusions every 4 hours 6 hours continuous infusion every 1 hour 4 hours . ( 2.3 ) calcium gluconate injection physically compatible fluids containing phosphate bicarbonate . precipitation may result mixed . fpi incompatibilities . ( 2.5 )",
    "warningsAndPrecautions": "calcium gluconate sodium chloride injection clear , colorless solution supplied follows : strength unit sale 1,000 mg per 50 ml ( 20 mg per ml ) ndc 80830-2362-1 1 single-dose intravenous bag overwrap ndc 80830-2362-9 unit 24 ndc 80830-2362-2 unit 12 2,000 mg per 100 ml ( 20 mg per ml ) ndc 80830-2363-1 1 single-dose intravenous bag overwrap ndc 80830-2363-9 unit 24 ndc 80830-2363-2 unit 12 container closure made natural rubber latex . non-pvc , non-dehp , sterile . store 20° 25°c ( 68° 77°f ) [ usp controlled room temperature ] . product used within 60 days removal overwrap . preservative free . discard unused portion single-dose container immediately .",
    "adverseReactions": "calcium gluconate sodium chloride injection contraindicated : hypercalcemia neonates ( 28 days age younger ) receiving ceftriaxone [ ( 5.2 ) ]",
    "indications_original": "Calcium gluconate in sodium chloride injection is indicated for pediatric and adult patients for the treatment of acute symptomatic hypocalcemia.\n                  \n                     Limitations of Use\n                  \n                  The safety of calcium gluconate injection for long term use has not been established.",
    "contraindications_original": "Contains 20 mg of calcium gluconate per mL which contains 1.86 mg (0.093 mEq) of elemental calcium. ( 2.1 ) Administer intravenously (bolus or continuous infusion) via a secure intravenous line. ( 2.1 ) See Full Prescribing Information (FPI) for administration rates and appropriate monitoring. ( 2.1 ) Do not dilute calcium gluconate in sodium chloride injection prior to use. Any unused portion should be discarded. ( 2.1 ) Individualize the dose within the recommended range in adults and pediatric patients depending on the severity of symptoms of hypocalcemia, the serum calcium level and the acuity of onset of hypocalcemia. See Table 2 in the FPI for dosing recommendations in mg of calcium gluconate for neonates, pediatric and adult patients. ( 2.2 ) Measure serum calcium during intermittent infusions every 4 hours to 6 hours and during continuous infusion every 1 hour to 4 hours. ( 2.3 ) Calcium gluconate injection is not physically compatible with fluids containing phosphate or bicarbonate. Precipitation may result if mixed. See FPI for all drug incompatibilities. ( 2.5 )",
    "warningsAndPrecautions_original": "Calcium Gluconate in Sodium Chloride Injection is a clear, colorless solution supplied as follows:\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              \n                                 Strength\n                              \n                           \n                           \n                              \n                                 Each\n                              \n                           \n                           \n                              \n                                 Unit of Sale\n                              \n                           \n                        \n                        \n                           \n                              1,000 mg per 50 mL \n                              \n                                 (20 mg per mL)\n                              \n                           \n                           \n                              NDC 80830-2362-1\n                              1 Single-dose Intravenous Bag in an Overwrap\n                           \n                           \n                              NDC 80830-2362-9\n                              Unit of 24\n                           \n                        \n                        \n                            \n            NDC 80830-2362-2\n            Unit of 12\n                        \n                        \n                           \n                              2,000 mg per 100 mL \n                              \n                                 (20 mg per mL)\n                              \n                           \n                           \n                              NDC 80830-2363-1\n                              1 Single-dose Intravenous Bag in an Overwrap\n                           \n                           \n                              NDC 80830-2363-9\n                              Unit of 24\n                           \n                        \n                        \n                            \n            NDC 80830-2363-2\n            Unit of 12\n                        \n                     \n                  \n                  The container closure is not made with natural rubber latex. Non-PVC, Non-DEHP, Sterile.\n                  Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Product should be used within 60 days of removal from overwrap.\n                  Preservative Free. Discard any unused portion in the single-dose container immediately.",
    "adverseReactions_original": "Calcium gluconate in sodium chloride injection is contraindicated in: \n                  \n                     Hypercalcemia \n                     Neonates (28 days of age or younger) receiving ceftriaxone [see Warnings and Precautions (5.2)]"
}